𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression

✍ Scribed by Philip J. Mease; Alan J. Kivitz; Francis X. Burch; Evan L. Siegel; Stanley B. Cohen; Peter Ory; David Salonen; Joel Rubenstein; John T. Sharp; Wayne Tsuji


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
109 KB
Volume
50
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Efficacy and safety of leflunomide in th
✍ J. Peter Kaltwasser; Peter Nash; Dafna Gladman; Cheryl F. Rosen; Frank Behrens; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 2 views

## Abstract ## Objective Current treatment options for psoriatic arthritis (PsA) are limited. Leflunomide, an oral pyrimidine synthesis inhibitor, is highly effective in the treatment of rheumatoid arthritis, and small studies have suggested similar efficacy in PsA. We undertook this double‐blind,

Markers for type II collagen breakdown p
✍ Robert Landewé; Piet Geusens; Maarten Boers; Désirée van der Heijde; Willem Lems 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 1 views

## Abstract ## Objective To investigate in a randomized clinical trial setting with an aggressive combination‐therapy arm and a mild‐monotherapy arm, whether therapy‐induced changes in urinary C‐terminal crosslinking telopeptide of type I collagen (CTX‐I) and type II collagen (CTX‐II) predict 5‐ye

A longitudinal study of the effect of di
✍ Janice A. Husted; Brian D. Tom; Vernon T. Farewell; Catherine T. Schentag; Dafna 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB 👁 2 views

## Abstract ## Objective To investigate whether there are differential effects of disease activity and damage on physical functioning as measured by the Health Assessment Questionnaire (HAQ) over the course of psoriatic arthritis (PsA). ## Methods Between June 1993 and March 2005, 382 patients a